AbbVie Inc. (SNSE:ABBVCL)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of CLP 368.77 trillion. The enterprise value is 427.12 trillion.

Market Cap	368.77T
Enterprise Value	427.12T

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	74.02%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 163.33 and the forward PE ratio is 16.52.

PE Ratio	163.33
Forward PE	16.52
PS Ratio	6.43
PB Ratio	-147.55
P/TBV Ratio	n/a
P/FCF Ratio	19.48
P/OCF Ratio	18.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.50, with an EV/FCF ratio of 22.57.

EV / Earnings	189.17
EV / Sales	7.76
EV / EBITDA	15.50
EV / EBIT	21.76
EV / FCF	22.57

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	1.04B
Profits Per Employee	41.05M
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-706.78B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.00%
50-Day Moving Average	171,590.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	29.67
Average Volume (20 Days)	0

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.15

Income Statement

In the last 12 months, AbbVie had revenue of CLP 57.35 trillion and earned 2.26 trillion in profits. Earnings per share was 1,269.91.

Revenue	57.35T
Gross Profit	40.99T
Operating Income	20.45T
Pretax Income	1.60T
Net Income	2.26T
EBITDA	28.39T
EBIT	20.45T
Earnings Per Share (EPS)	1,269.91

Balance Sheet

The company has 5.45 trillion in cash and 66.21 trillion in debt, giving a net cash position of -60,752.60 billion.

Cash & Cash Equivalents	5.45T
Total Debt	66.21T
Net Cash	-60,752.60B
Net Cash Per Share	n/a
Equity (Book Value)	-2,499.22B
Book Value Per Share	-1,437.50
Working Capital	-10,435.39B

Cash Flow

In the last 12 months, operating cash flow was 20.06 trillion and capital expenditures -1,130.85 billion, giving a free cash flow of 18.93 trillion.

Operating Cash Flow	20.06T
Capital Expenditures	-1,130.85B
Free Cash Flow	18.93T
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 6,400.30, which amounts to a dividend yield of 3.73%.

Dividend Per Share	6,400.30
Dividend Yield	3.73%
Dividend Growth (YoY)	343.48%
Years of Dividend Growth	2
Payout Ratio	481.49%
Buyback Yield	-0.01%
Shareholder Yield	3.72%
Earnings Yield	0.61%
FCF Yield	5.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7